
Y-mAbs Announces Data to be Presented at the 55th Congress of the International Society of Pediatric Oncology 21 September 2023
NEW YORK, Sept. 21, 2023 (GLOBE NEWSWIRE) — Y-mAbs Therapeutics, Inc. (the “Company”... Read more
NEW YORK, Sept. 21, 2023 (GLOBE NEWSWIRE) — Y-mAbs Therapeutics, Inc. (the “Company”... Read more
Full enrolment and dosing commenced with its novel, prophylactic GBS vaccine in both healthy older adults... Read more
The Annual General Meeting in DANISH BIO-DANSK BIOTEK was held on 11 May 2023 at Børsen. The Minutes... Read more
NEW YORK, May 26, 2023 (GLOBE NEWSWIRE) — Y-mAbs Therapeutics, Inc. (the “Company” or “Y-mAbs”)... Read more
NEW YORK, May 26, 2023 (GLOBE NEWSWIRE) — Y-mAbs Therapeutics, Inc. (the “Company” or “Y-mAbs”)... Read more
May 23, 2023PDF VersionNEW YORK, May 23, 2023 (GLOBE NEWSWIRE) — Y-mAbs Therapeutics,... Read more
BOSTON, May 23, 2023 (GLOBE NEWSWIRE) — Galecto, Inc. (NASDAQ: GLTO), a clinical-stage biotechnology... Read more
Q1 2023 DANYELZA® record net product revenues of $20.3 million, driving YoY growth of 93% and a 24%... Read more
Apr 28, 2023PDF VersionNEW YORK, April 28, 2023 (GLOBE NEWSWIRE) — Y-mAbs Therapeutics,... Read more